A deletion mutant derived from herpes simplex virus type 1 (HSV-1) strain ANG was analysed. The deletion mapped within the polypeptide-coding region of the immediate-early ICP4 gene. Based on DNA sequence data the deletion was shown to comprise 84 base pairs. In the wild-type genome of strain ANG these sequences were almost completely homologous to the known sequences of HSV-1 strain 17. The ICP4 polypeptide induced by the mutant was similar in size to the wild-type ICP4 protein and was recognized by a monoclonal antibody against ICP4. The data presented suggest that the deletion corresponds to a region on the ICP4 polypeptide that is nonessential for the replication of the virus in vitro.
At least five immediate-early (IE) proteins can be identified during the infectious cycle of herpes simplex virus type I (HSV-I ; Honess & Roizman, 1974; Preston, 1979) . The synthesis of these polypeptides is not dependent on the prior synthesis of other viral proteins. The IE polypeptide variously referred to as VP175 (Courtney & Benyesh-Melnick, 1974) or Vmw175 (Marsden et al., 1976) or ICP4 (Honess & Roizman, 1974 ) is the only IE gene product to which an essential function in replication has been assigned. Studies with temperature-sensitive mutants have shown that the ICP4 gene product is involved in the switch from immediate-early (ct) protein synthesis to the synthesis of early (fl) proteins and that it is required in a functional form throughout the infectious cycle (Marsden et al., 1976; Parris et al., 1978; Knipe et al., 1978 ; Schaffer et al., 1978; Watson & Clements, 1978; Preston, 1979) . The lesions of the ts mutants analysed so far map within the coding sequences of the ICP4 gene. The fact that the mutants all display a low but measurable reversion frequency is taken as evidence that the lesions represent point mutations. In the case of the mutant tsK, a point mutation has been confirmed by DNA sequencing (Davison et al., t984) .
In this paper we describe a deletion mutant in the ICP4 gene that arose spontaneously in transfection experiments with genomic DNA of HSV-1 ANG path (Kaerner et al., 1983) . In these experiments, variants had been obtained at a low frequency which formed small syncytial plaques, in contrast to the wild-type (w.t.) virus which induces large syncytial plaques. Analysis of the genome of 12 such variants resulted in the identification of one mutant virus with an apparent deletion in the short repeat sequences (Rs). The plaque-forming capacity of this mutant at 39.5 °C was reduced by a factor of 20, its capacity to replicate by a factor of 1000.
In Fig. l the BamHI restriction fragment pattern of the mutant DNA is compared to that of w.t. DNA. The mutant pattern is different in that it lacks a band of DNA migrating like w.t. fragment Y, which maps within the Rs (Wilkie et al., 1978) and therefore is generated twice per genome. A new fragment shows a migration behaviour of a DNA species which is about 100 nucleotides shorter than the w.t. fragment Y. From the sequence data of Murchie & McGeoch (1982) it can be concluded that any mutation affecting the 1844 base pair BamHI Y fragment 0000-6503 © 1985 SGM et al., 1979) . However, the lesion could still reside within the 275 base pairs of the 5" non-coding region of the gene (Murchie & McGeoch, 1982) which are also part of fragment Y. In order to carry out a fine mapping of the mutation in B a m H I Y, both the w.t. fragment and the faster-migrating fragment of the mutant were cloned into pBR322. Cleavage of the cloned w.t. fragment with SmaI and HinfI yielded the same set of fragments that had been mapped previously by Rixon et al. (1982) as shown in Fig. 2(a) . Similar patterns of subfragments were obtained with the smaller mutant fragment except for SmaI D and HinfI A (Fig. 2a) both of which appeared to be shortened. These results characterized the alteration of the mutant as a deletion in B a m H I Y .
Fundamental to the precise localization of the deletion by D N A sequencing (Maxam & Gilbert, 1980) was its position within HinfI fragment A close to the HinfI A/B cleavage site (Fig.  2a) . The sequence data obtained by Murchie & McGeoch (1982) (Towbin et al., 1979) and exposed to the 58S antibody (Showalter et al., 1981 ) . Bound 58S antibody was detected by peroxidase-conjugated goat antimouse antibody. Autoradiographs of lanes (a) determined were residues 570 to 713 for the w.t. type and residues 570 to 786 for the mutant; this numeration takes as number 1 the first residue of the presumed translation initiator codon (Murchie & McGeoch, 1982) . The sequences presented in Fig. 2(b) indicate that the deletion of the mutant spans bases 625 to 710. The 84-base in-frame deletion should lead to an altered ICP4 polypeptide since there is no evidence for splicing in the IE m R N A -3 coding for the ICP4 gene product (Rixon et al., 1982) . The synthesis of IE polypeptides, especially of ICP4, in cells infected either with HSV-1 A N G path or with the mutant virus was studied following the cycloheximide/actinomycin D protocol (Honess & Roizman, 1974) . S D S -P A G E analysis of IE proteins labelled with ~4C-amino acids revealed similar patterns. In an immunoblot analysis (Fig. 3) , both the mutant and the w.t. ICP4 polypeptide reacted with the 58S antibody which specifically recognizes this protein (Showalter et al., 1982) . No difference in the migration behaviour of the ICP4 polypeptides was observed.
For a further characterization of the mutant, rescue experiments were attempted on the basis of the difference in plaque phenotype between w.t. and mutant virus. These experiments were carried out by cotransfection of mutant genomic D N A together with w.t. B a m H I Y D N A . In control experiments the mutant B a m H I Y fragment was used. In both cases we obtained virus clones forming large syncytial plaques indistinguishable from those of the w.t. virus. These clones were found not to be temperature-sensitive in plaque-forming capacity, like the original mutant, and their virus yields in a single cycle of replication at 39.5°C were only marginally, by a factor of five, lower than in w.t. infection. In the cases examined by restriction enzyme analysis the deletion was still present regardless of whether the w.t. or the mutant fragment Y had been used for cotransfection. Apparently there is no absolute link between the deletion and the phenotypic markers, if at all. In any case the markers cannot be used in rescue experiments.
Variations in the length of B a m H I Y have been reported by Lonsdale et al. (1980) to occur among independent virus isolates. The length differences, however, did not exceed 30 nucleotides, and these insertions or deletions have not been mapped within B a m H I Y . Short communication A large number of temperature-sensitive mutants in the ICP4 gene have been described. Mapping data for 13 such mutants are available and show that the mutated sequences in most cases are not located near the deletion described here (Dixon & Schaffer, 1980; Preston, 1981 ; DeLuca et al., 1984) . Eleven of the 13 mutations do not map in the BamHI Y fragment. One of the remaining two mutations, tsK, has been sequenced and was found to represent a point mutation at residue 1424 (Davison et al., 1984) . The other mutation studied, tsLB2, has not been located unambiguously. The fact that mutations to temperature sensitivity have been found to map outside the ICP4 gene region under study here could indicate a relative insignificance of changes in the amino acids encoded in this DNA region. Further arguments in support of this can be derived from the comparison of DNA sequences of HSV-1 ANG path, its deletion mutant and HSV-I strain 17 (Murchie & McGeoch, 1982) . In the 217 bp sequence of HSV-1 ANG path which we have determined (Fig. 2b) , four residues can be identified that are different and result in amino acid changes (position 595/596 Ser to Asp; position 638 His to Arg; position 656 Ala to Val). This variability, together with the described deletion, allows the conclusion that the affected parts of the ICP4 molecule may not be essential for its function in the replication of HSV-1 in vitro.
